{
  "url": "https://openlegislation.uk/health-and-care-act-2022-consequential-and-related-amendments-and-transitional-provisions-regulations-2022/regulation-19",
  "json_url": "https://openlegislation.uk/health-and-care-act-2022-consequential-and-related-amendments-and-transitional-provisions-regulations-2022/regulation-19.json",
  "legislation": "uksi/2022/634",
  "legislation_title": "The Health and Care Act 2022 (Consequential and Related Amendments and Transitional Provisions) Regulations 2022",
  "legislation_url": "https://openlegislation.uk/health-and-care-act-2022-consequential-and-related-amendments-and-transitional-provisions-regulations-2022",
  "path": "regulation/19",
  "kind": "regulation",
  "number": "19",
  "heading": "Amendment of the Medicines for Human Use (Clinical Trials) Regulations 2004",
  "text": "(1) The Medicines for Human Use (Clinical Trials) Regulations 2004 are amended as follows.\n(2) In Schedule 2—\n(a) in paragraph 3 for sub-paragraph (5)(b)(iii)(cc) substitute—\n“(cc) an integrated care board.”.\n(b) in paragraph 6, in sub-paragraph (6)(a)(ii) for “the governing body of a clinical commissioning group” substitute “an integrated care board”.",
  "extent": null,
  "status": null,
  "version": "current",
  "annotations": [
    {
      "type": "footnote",
      "label": "f1",
      "text": "S.I. 2004/1031, amended by S.I. 2012/1641; there are other amending instruments but none is relevant."
    }
  ],
  "outstanding_effects": [],
  "provenance": {
    "source": "legislation.gov.uk",
    "source_url": "https://www.legislation.gov.uk/uksi/2022/634/regulation/19",
    "retrieved_at": "2026-10-28T21:59:08.811192+00:00"
  },
  "licence": "Open Government Licence v3.0",
  "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/",
  "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives."
}